keyword
MENU ▼
Read by QxMD icon Read
search

Ricardo Barbuti

keyword
https://www.readbyqxmd.com/read/26064098/standard-triple-therapy-versus-sequential-therapy-in-helicobacter-pylori-eradication-a-double-blind-randomized-and-controlled-trial
#1
Jaime Natan Eisig, Tomás Navarro-Rodriguez, Ana Cristina Sá Teixeira, Fernando Marcuz Silva, Rejane Mattar, Decio Chinzon, Christiane Haro, Márcio Augusto Diniz, Joaquim Prado Moraes-Filho, Ronnie Fass, Ricardo Correa Barbuti
Aim. To compare 10-day standard triple therapy versus sequential therapy as first-line treatment in patients infected with H. pylori. Methods. One hundred H. pylori positive patients (diagnosed by rapid urease test and histology), with average age of 47.2, M/F = 28/72, were randomized to receive either standard triple treatment (TT) as follows: lansoprazole 30 mg, clarithromycin 500 mg, and amoxicillin 1 g, b.i.d. for ten days, or sequential treatment (ST) as follows: lansoprazole 30 mg, amoxicillin and placebo 1...
2015: Gastroenterology Research and Practice
https://www.readbyqxmd.com/read/26039946/efficacy-of-levofloxacin-amoxicillin-and-a-proton-pump-inhibitor-in-the-eradication-of-helicobacter-pylori-in-brazilian-patients-with-peptic-ulcers
#2
Fernando Marcuz Silva, Elaine Cristina Silveira de Queiroz, Tomás Navarro-Rodriguez, Ricardo Correa Barbuti, Rejane Mattar, Kiyoshi Iriya, Jin Hwa Lee, Jaime Natan Eisig
OBJECTIVES: The eradication of Helicobacter (H.) pylori allows peptic ulcers in patients infected with the bacteria to be cured. Treatment with the classic triple regimen (proton pump inhibitor, amoxicillin and clarithromycin) has shown decreased efficacy due to increased bacterial resistance to clarithromycin. In our country, the eradication rate by intention to treat with this regimen is 83%. In Brazil, a commercially available regimen for bacterial eradication that uses levofloxacin and amoxicillin with lansoprazole is available; however, its efficacy is not known...
May 2015: Clinics
https://www.readbyqxmd.com/read/24868330/rare-cause-of-abdominal-incidentaloma-hepatoduodenal-ligament-teratoma
#3
Vagner Birk Jeismann, Rodrigo Blanco Dumarco, Celso di Loreto, Ricardo Correa Barbuti, José Jukemura
The occurrence of a hepatoduodenal ligament teratoma is extremely rare, with only a few cases reported in the literature. This case report describes the discovery of a hepatoduodenal ligament lesion revealed during abdominal ultrasonography for cholelithiasis-related abdominal pain in a 27-year-old female. Cross-sectional imaging identified a 5 cm × 4 cm heterogeneous mass of fat tissue with irregular calcification located in the posterior-superior aspect of the head of the pancreas. An encapsulated lesion showing no invasion to the common bile duct or adjacent organs and vessels was exposed during laparotomy and resected...
May 27, 2014: World Journal of Gastrointestinal Surgery
https://www.readbyqxmd.com/read/24499444/endoscopic-findings-in-uninvestigated-dyspepsia
#4
Jacob Jehuda Faintuch, Fernando Marcuz Silva, Tomás Navarro-Rodriguez, Ricardo Correa Barbuti, Claudio Lyoiti Hashimoto, Alessandra Rita Asayama Lopes Rossini, Marcio Augusto Diniz, Jaime Natan Eisig
BACKGROUND: It is important to know the causes of dyspepsia to establish the therapeutic approach. Dyspepsia is a frequent syndrome in our country, where there are restrictions to endoscopy and high prevalence of Helicobacter pylori (H. pylori) infection. This study aimed to assess the endoscopic findings of the syndrome, in an outpatient screening clinic of a tertiary hospital in São Paulo. METHODS: Outpatients with uninvestigated dyspepsia, according to Rome III criteria, answered a dyspepsia questionnaire and underwent esophagogastroduodenoscopy...
2014: BMC Gastroenterology
https://www.readbyqxmd.com/read/23530767/association-of-a-probiotic-to-a-helicobacter-pylori-eradication-regimen-does-not-increase-efficacy-or-decreases-the-adverse-effects-of-the-treatment-a-prospective-randomized-double-blind-placebo-controlled-study
#5
RANDOMIZED CONTROLLED TRIAL
Tomás Navarro-Rodriguez, Fernando Marcuz Silva, Ricardo Correa Barbuti, Rejane Mattar, Joaquim Prado Moraes-Filho, Maricê Nogueira de Oliveira, Cristina S Bogsan, Décio Chinzon, Jaime Natan Eisig
BACKGROUND: The treatment for the eradication of Helicobacter pylori (H. pylori) is complex; full effectiveness is rarely achieved and it has many adverse effects. In developing countries, increased resistance to antibiotics and its cost make eradication more difficult. Probiotics can reduce adverse effects and improve the infection treatment efficacy.If the first-line therapy fails a second-line treatment using tetracycline, furazolidone and proton-pump inhibitors has been effective and low cost in Brazil; however it implies in a lot of adverse effects...
2013: BMC Gastroenterology
https://www.readbyqxmd.com/read/22147131/helicobacter-pylori-antibiotic-resistance-in-brazil-clarithromycin-is-still-a-good-option
#6
Jaime Natan Eisig, Fernando Marcuz Silva, Ricardo Correa Barbuti, Tomás Navarro-Rodriguez, Joaquim Prado P Moraes-Filho, José Pedrazzoli Jr
CONTEXT: The antibiotic susceptibility is the cornerstone for the eradication therapies of Helicobacter pylori. OBJECTIVES: To evaluate the prevalence of primary resistance of H. pylori was evaluated in an urban Brazilian population. METHODS: H. pylori isolates were obtained from patients submitted to an upper gastrointestinal endoscopy for the evaluation of dyspeptic symptoms. Biopsies from antrum, corpus and fundus were taken to determine the antibiotic susceptibility of H...
October 2011: Arquivos de Gastroenterologia
https://www.readbyqxmd.com/read/21655746/eosinophilic-esophagitis-in-patients-with-typical-gastroesophageal-reflux-disease-symptoms-refractory-to-proton-pump-inhibitor
#7
Claudia Cristina de Sá, Humberto Setsuo Kishi, Ana Luiza Silva-Werneck, Joaquim Prado Pinto de Moraes-Filho, Jaime Natan Eisig, Ricardo Correa Barbuti, Claudio Lyioti Hashimoto, Tomas Navarro-Rodriguez
BACKGROUND: TREATMEN The contribution of eosinophilic esophagitis (EoE) to refractory gastroesophageal reflux disease (GERD) remains unknown. When EoE and GERD overlap, the clinical, endoscopic and histological findings are nonspecific and cannot be used to distinguish between the two disorders. Limited data are available on this topic, and the interaction between EoE and GERD is a matter of debate. AIM: We have conducted a prospective study of adult patients with refractory GERD to evaluate the overlap of reflux and EoE...
2011: Clinics
https://www.readbyqxmd.com/read/21252448/clarithromycin-based-triple-therapy-for-helicobacter-pylori-treatment-in-peptic-ulcer-patients
#8
Guilherme Felga, Fernando Marcuz Silva, Ricardo Correa Barbuti, Tomas Navarro-Rodriguez, Schlioma Zaterka, Jaime Natan Eisig
INTRODUCTION: The scheme proton pump inhibitor/amoxicillin/clarithromycin (PPI/AC) is still the first-line treatment for Helicobacter pylori (H. pylori) infections despite evidence suggesting its failure in up to 20% to 30% of patients. METHODOLOGY: This study involved 493 patients who were prescribed omeprazole (20 mg twice a day) or another proton pump inhibitor in equivalent dosage, amoxicillin (1 g twice a day), and clarithromycin (500 mg twice a day) for seven days...
November 2010: Journal of Infection in Developing Countries
https://www.readbyqxmd.com/read/20520983/guidelines-for-the-diagnosis-and-management-of-gastroesophageal-reflux-disease-an-evidence-based-consensus
#9
Joaquim Prado P Moraes-Filho, Tomas Navarro-Rodriguez, Ricardo Barbuti, Jaime Eisig, Decio Chinzon, Wanderley Bernardo
Gastroesophageal reflux disease (GERD) is one of the most common disorders in medical practice. A number of guidelines and recommendations for the diagnosis and management of GERD have been published in different countries, but a Brazilian accepted directive by the standards of evidence-based medicine is still lacking. As such, the aim of the Brazilian GERD Consensus Group was to develop guidelines for the diagnosis and management of GERD, strictly using evidence-based medicine methodology that could be clinically used by primary care physicians and specialists and would encompass the needs of physicians, investigators, insurance and regulatory bodies...
January 2010: Arquivos de Gastroenterologia
https://www.readbyqxmd.com/read/20302589/helicobacter-pylori-reinfection-in-brazilian-patients-with-peptic-ulcer-disease-a-5-year-follow-up
#10
Fernando M Silva, Tomas Navarro-Rodriguez, Ricardo C Barbuti, Rejane Mattar, Claudio L Hashimoto, Jaime N Eisig
BACKGROUND: The Helicobacter pylori reinfection seems to be higher in developing countries, than in developed ones. The aim of the study was to determine the annual recurrence rate of H. pylori, in Brazilian patients with peptic ulcer disease, in a 5-year follow-up. METHODS: Patients, with peptic ulcer disease diagnosed by upper digestive endoscopy (UDE) and H. pylori infection verified by histological analysis, rapid urease test, polymerase chain reaction, and urea breath test (UBT), were treated for bacterial eradication...
February 2010: Helicobacter
https://www.readbyqxmd.com/read/19918687/neither-genotype-nor-the-gastric-colonization-site-of-helicobacter-pylori-are-predictive-factors-for-the-development-of-erosive-esophagitis-in-patients-with-peptic-ulcer-disease-1-year-after-eradication
#11
Carlos Alexandre Gonçalves Batista, Fernando Marcuz Silva, Ricardo Correa Barbuti, Jaime Natan Eisig, Rejane Mattar, Tomás Navarro-Rodriguez
CONTEXT: Whether Helicobacter pylori infection is a protective or predisposing factor for the development of gastroesophageal reflux disease remains controversial. The most virulent strains, such as those expressing the cytotoxin-associated gene A (CagA), and the site of gastric colonization have been correlated with the prevention or development of esophagitis. AIM: To determine the incidence of erosive esophagitis following eradication of H. pylori in patients with peptic ulcer disease and to evaluate the association of erosive esophagitis with virulent strains of H...
July 2009: Arquivos de Gastroenterologia
https://www.readbyqxmd.com/read/19690664/comorbidities-are-frequent-in-patients-with-gastroesophageal-reflux-disease-in-a-tertiary-health-care-hospital
#12
Joaquim Prado P Moraes-Filho, Tomás Navarro-Rodriguez, Jaime N Eisig, Ricardo C Barbuti, Decio Chinzon, Eamonn M M Quigley
INTRODUCTION: Several aspects of gastroesophageal reflux disease (GERD) have been studied, but the frequency of comorbidities is not yet fully understood. OBJECTIVES: To study the prevalence of GERD comorbidities in a tertiary care hospital. METHODS: We prospectively studied 670 consecutive adult patients from the outpatient department of our facility. A diagnosis was established using clinical, endoscopic and/or pHmetry-related findings. Each patient's medical file was reviewed with respect to the presence of other medical conditions and diagnoses...
2009: Clinics
https://www.readbyqxmd.com/read/19470177/efficacy-of-a-7-day-course-of-furazolidone-levofloxacin-and-lansoprazole-after-failed-helicobacter-pylori-eradication
#13
Jaime N Eisig, Fernando M Silva, Ricardo C Barbuti, Tomás Navarro Rodriguez, Peter Malfertheiner, Joaquim P P Moraes Filho, Schlioma Zaterka
BACKGROUND: Increasing resistance to clarithromycin and nitroimidazole is the main cause of failure in the Helicobacter pylori eradication. The ideal retreatment regimen remains unclear, especially in developing countries, where the infection presents high prevalence and resistance to antibiotics. The study aimed at determining the efficacy, compliance and adverse effects of a regimen that included furazolidone, levofloxacin and lansoprazole in patients with persistent Helicobacter pylori infection, who had failed to respond to at least one prior eradication treatment regimen...
2009: BMC Gastroenterology
https://www.readbyqxmd.com/read/18985815/quadruple-therapy-with-furazolidone-for-retreatment-in-patients-with-peptic-ulcer-disease
#14
Guilherme-Eduardo-Goncalves Felga, Fernando-Marcuz Silva, Ricardo-Correa Barbuti, Tomas Navarro-Rodriguez, Schlioma Zaterka, Jaime-Natan Eisig
AIM: To establish the efficacy and safety of a 7-d therapeutic regimen using omeprazole, bismuth subcitrate, furazolidone and amoxicillin in patients with peptic ulcer disease who had been previously treated with other therapeutic regimens without success. METHODS: Open cohort study which included patients with peptic ulcer who had previously been treated unsuccessfully with one or more eradication regimens. The therapeutic regimen consisted of 20 mg omeprazole, 240 mg colloidal bismuth subcitrate, 1000 mg amoxicillin, and 200 mg furazolidone, taken twice a day for 7 d...
October 28, 2008: World Journal of Gastroenterology: WJG
https://www.readbyqxmd.com/read/18510773/short-term-triple-therapy-with-azithromycin-for-helicobacter-pylori-eradication-low-cost-high-compliance-but-low-efficacy
#15
Fernando M Silva, Jaime N Eisig, Ana Cristina S Teixeira, Ricardo C Barbuti, Tomás Navarro-Rodriguez, Rejane Mattar
BACKGROUND: The Brazilian consensus recommends a short-term treatment course with clarithromycin, amoxicillin and proton-pump inhibitor for the eradication of Helicobacter pylori (H. pylori). This treatment course has good efficacy, but cannot be afforded by a large part of the population. Azithromycin, amoxicillin and omeprazole are subsidized, for several aims, by the Brazilian federal government. Therefore, a short-term treatment course that uses these drugs is a low-cost one, but its efficacy regarding the bacterium eradication is yet to be demonstrated...
2008: BMC Gastroenterology
https://www.readbyqxmd.com/read/16358139/a-furazolidone-based-quadruple-therapy-for-helicobacter-pylori-retreatment-in-patients-with-peptic-ulcer-disease
#16
Jaime Natan Eisig, Fernando Marcuz Silva, Tomás Navarro Rodriguez, Cláudio Lyoti Hashimoto, Ricardo Correa Barbuti
PURPOSE: Many of the currently used eradication regimens against Helicobacter pylori fail to cure the infection either due to antimicrobial resistance or to poor patient compliance. The infection leads to increased risk of developing potentially severe complications, such as gastric cancer. This study was aimed at assessing the efficacy and safety of a quadruple therapy with furazolidone for H. pylori retreatment. METHODS: Patients who had failed one or more eradication regimens against H...
December 2005: Clinics
https://www.readbyqxmd.com/read/15667482/lugol-s-dye-spray-chromoendoscopy-establishes-early-diagnosis-of-esophageal-cancer-in-patients-with-primary-head-and-neck-cancer
#17
Claudio L Hashimoto, Kiyoshi Iriya, Elisa R Baba, Tomas Navarro-Rodriguez, Maria C Zerbini, Jaime N Eisig, Ricardo Barbuti, Decio Chinzon, Joaquim Prado P Moraes-Filho
OBJECTIVE: Patients with primary head and neck cancer show a predisposition to develop esophageal cancer. The aim of this study was to investigate in these patients: the prevalence of esophageal cancer comparing the value of chromoendoscopy using Lugol's solution examination to standard endoscopy, in the early diagnosis of esophageal cancer. METHODS: Prospective observational study at a state general university hospital in Sao Paulo, Brazil. 326 consecutive adult patients with primary head and neck cancer were evaluated...
February 2005: American Journal of Gastroenterology
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"